The chimeric vaccine construct was designed to contain multiple immunogenic epitopes capable of stimulating B‐cells, HTL, CTL, and IFN‐ɣ, which are essential components of the immune response against viral infections. This evidence concerns the gene IFNA1 and viral infectious disease.